Arax Advisory Partners’s Prelude Therapeutics PRLD Stock Holding History

Arax Advisory Partners’s Portfolio PRLD Stock Details PRLD Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$22	Buy
2024 Q4	–	Sell
2024 Q3	$40	Hold
2024 Q2	$73	Buy